User:Ryan Walsh: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
 
Line 30: Line 30:
#Paper1 pmid=6947258
#Paper1 pmid=6947258
#Paper2 pmid=13718526
#Paper2 pmid=13718526
1. Walsh R, Martin E, Darvesh S. Limitations of conventional inhibitor classifications. Integr Biol (Camb). 2011 Oct 31. [Epub ahead of print]
2. Walsh R, Rockwood K, Martin E, Darvesh S. Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram. Biochim Biophys Acta. 2011 Aug 19;1810(12):1230-1235.
3. Shevchenko Y, Francis TJ, Blair DA, Walsh R, DeRosa MC, Albert J. In situ biosensing with a surface plasmon resonance fiber grating aptasensor. Anal Chem. 2011 Sep 15;83(18):7027-34.
4. Holahan MR, Madularu D, McConnell EM, Walsh R, DeRosa MC. Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia. PLoS One. 2011;6(7):e22239.
5. Rockwood K, Walsh R, Martin E, Darvesh S. Potentially procholinergic effects of medications commonly used in older adults. Am J Geriatr Pharmacother. 2011 Feb;9(1):80-7.
6. Darvesh S, Pottie IR, Darvesh KV, McDonald RS, Walsh R, Conrad S, Penwell A, Mataija D, Martin E. Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants. Bioorg Med Chem. 2010 Mar 15;18(6):2232-44.
7. DeRosa MC, Monreal C, Schnitzer M, Walsh R, Sultan Y. Nanotechnology in fertilizers. Nat Nanotechnol. 2010 Feb;5(2):91.
8. Walsh R, Martin E, Darvesh S. A method to describe enzyme-catalyzed reactions by combining steady state and time course enzyme kinetic parameters. Biochim Biophys Acta. 2010 Jan;1800(1):1-5.
9. Walsh R, DeRosa MC. Retention of function in the DNA homolog of the RNA dopamine aptamer. Biochem Biophys Res Commun. 2009 Oct 30;388(4):732-5.
10. Sultan Y, Walsh R, Monreal C, DeRosa MC. Preparation of functional aptamer films using layer-by-layer self-assembly. Biomacromolecules. 2009 May 11;10(5):1149-54.
11. Darvesh S, Darvesh KV, McDonald RS, Mataija D, Walsh R, Mothana S, Lockridge O, Martin E. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase. J Med Chem. 2008 Jul 24;51(14):4200-12.
12. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Conrad S, Gomez G, Walsh R, Martin E. Selective reversible inhibition of human butyrylcholinesterase by aryl amide derivatives of phenothiazine. Bioorg Med Chem. 2007 Oct 1;15(19):6367-78.
13. Walsh R, Martin E, Darvesh S. A versatile equation to describe reversible enzyme inhibition and activation kinetics: modeling beta-galactosidase and butyrylcholinesterase. Biochim Biophys Acta. 2007 May;1770(5):733-46.
14. Darvesh S, Walsh R, Martin E. Homocysteine thiolactone and human cholinesterases. Cell Mol Neurobiol. 2007 Feb;27(1):33-48.
15. Darvesh S, McDonald RS, Darvesh KV, Mataija D, Mothana S, Cook H, Carneiro KM, Richard N, Walsh R, Martin E. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases. Bioorg Med Chem. 2006 Jul 1;14(13):4586-99.
16. Darvesh S, McDonald RS, Penwell A, Conrad S, Darvesh KV, Mataija D, Gomez G, Caines A, Walsh R, Martin E. Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives. Bioorg Med Chem. 2005 Jan 3;13(1):211-22.
17. Darvesh S, Martin E, Walsh R, Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin Biochem. 2004 Jan;37(1):42-9.
18. Darvesh S, Walsh R, Kumar R, Caines A, Roberts S, Magee D, Rockwood K, Martin E Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis Assoc Disord. 2003 Apr-Jun;17(2):117-26.
19. Darvesh S, Walsh R, Martin E. Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases. Cell Mol Neurobiol. 2003 Feb;23(1):93-100.
20. Darvesh S, Kumar R, Roberts S, Walsh R, Martin E. Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin. Cell Mol Neurobiol. 2001 Jun;21(3):285-96.
// leave a comment about a paper here
// leave a comment about a paper here
#Book1 isbn=0879697164
#Book1 isbn=0879697164

Revision as of 10:38, 8 November 2011

I am a new member of OpenWetWare!

Contact Info

Ryan Walsh (an artistic interpretation)

I work in the Your Lab at XYZ University. I learned about OpenWetWare from nature biobrick article a few years ago I believe, and I've joined because My supervisor has started a lab page.

Education

  • Year, PhD, Institute
  • Year, MS, Institute
  • Year, BS, Institute

Research interests

  1. Interest 1
  2. Interest 2
  3. Interest 3

Publications

  1. Goldbeter A and Koshland DE Jr. An amplified sensitivity arising from covalent modification in biological systems. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6840-4. DOI:10.1073/pnas.78.11.6840 | PubMed ID:6947258 | HubMed [Paper1]
  2. JACOB F and MONOD J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 1961 Jun;3:318-56. DOI:10.1016/s0022-2836(61)80072-7 | PubMed ID:13718526 | HubMed [Paper2]

    leave a comment about a paper here

  3. ISBN:0879697164 [Book1]

All Medline abstracts: PubMed | HubMed

Useful links

Retrieved from "https://openwetware.org/mediawiki/index.php?title=User:Ryan_Walsh&oldid=565201"